Abstract: A method of determining a prognosis of a cancer in a human comprising: determining expression level of CHST11 in a cancer tissue sample or determining methylation status of CHST11 gene in a cancer tissue sample. CHST11 is Carbohydrate (Chondroitin 4) Sulfotransferase 11.

Abstract: In various embodiments, a system comprises a map and a patient data assessment module. The map includes a plurality of groupings and interconnections of the groupings, each grouping having one or more patient members that share biological similarities, each interconnection interconnecting groupings that share at least one common patient member, the map identifying a set of groupings and a set of interconnections having a medical characteristic of a set of medical characteristics. The patient data assessment module may be configured to receive sensor data from a user's mobile device and to assess the sensor data to generate user medical attributes, to determine whether the user shares the biological similarities with the one or more patient members of each grouping based, at least in part, on the user medical attributes, thereby enabling association of the user with one or more of the set of medical characteristics.